4.655
Myriad Genetics Inc (MYGN) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
1.99%
209.80
|
205.70 | 213.10 | 195.90 | 210.60 |
| Cost Of Revenue |
1.78%
63.00
|
61.90 | 61.30 | 61.70 | 59.70 |
| Gross Profit |
2.09%
146.80
|
143.80 | 151.80 | 134.20 | 150.90 |
|
|
8.74%
152.50
|
167.10 | 481.00 | 163.20 | 189.90 |
| Benefits Costs and Expenses |
5.69%
218.70
|
231.90 | 543.70 | 225.30 | 249.70 |
| Costs And Expenses |
5.69%
218.70
|
231.90 | 543.70 | 225.30 | 249.60 |
| Depreciation and Amortization |
0.00%
12.60
|
12.60 | 14.10 | 14.40 | 14.80 |
| Operating Income/Loss |
75.54%
-5.70
|
-23.30 | -329.20 | -29.00 | -39.00 |
| Nonoperating Income/Loss |
10.34%
-3.20
|
-2.90 | -1.40 | -0.40 | -0.10 |
| Income/Loss From Continuing Operations Before Tax |
66.03%
-8.90
|
-26.20 | -330.60 | -29.40 | -39.10 |
| Income Tax Expense/Benefit |
183.33%
-1.00
|
1.20 | -0.10 | -29.30 | 3.40 |
| Income/Loss From Continuing Operations After Tax |
71.17%
-7.90
|
-27.40 | -330.50 | -0.10 | -42.50 |
|
|
71.17%
-7.90
|
-27.40 | -330.50 | -0.10 | -42.50 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.68%
0.30
|
93.10 | 92.50 | 91.40 | 0.10 |
| Diluted Average Shares |
99.68%
0.30
|
93.10 | 92.50 | 91.40 | 0.10 |
| Basic Earnings Per Share |
75.86%
-0.07
|
-0.29 | -3.57 | - | -0.47 |
| Diluted Earnings Per Share |
75.86%
-0.07
|
-0.29 | -3.57 | - | -0.47 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):